Concepedia

Jeffrey Siegel

JS

Statistics

Publications

33

Citations

10.1K

H-Index

27

Active since

1982

Affiliations

University of California, Los Angeles(Current)

University College London

University of Michigan

Délégation Paris 5

Université Paris Cité

Jeffrey Siegel is an author at University of California, Los Angeles specializing in immunology, medicine, and rheumatology.

ORCID

Publications per year

1982–2025

33

Publications

33

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

Joseph Keane, Sharon K. Gershon, Robert P. Wise et al. · New England Journal of Medicine · 2001 · 3.7K citations · Full text

, , +16

Demyelination occurring during anti-tumor necrosis factor ? therapy for inflammatory arthritides

Niveditha Mohan, Evelyne T. Edwards, Thomas R. Cupps et al. · Arthritis & Rheumatism · 2001 · 816 citations

, , +17

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

David T. Felson, Josef S Smolen, George A. Wells et al. · Annals of the Rheumatic Diseases · 2011 · 771 citations · Full text

, , +13

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

Dinesh Khanna, Christopher P. Denton, Angelika Jahreis et al. · The Lancet · 2016 · 669 citations · Full text

, , +5

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 652 citations · Full text

, , +4

1–5 of 33